BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25337279)

  • 1. Thyroid cancer in systemic lupus erythematosus: a meta analysis.
    Zhang M; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Li XP
    Int J Clin Exp Pathol; 2014; 7(9):6270-3. PubMed ID: 25337279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
    Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
    Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
    Huang HB; Jiang SC; Han J; Cheng QS; Dong CB; Pan CM
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia.
    Liu H; Ding Q; Yang K; Zhang T; Li G; Wu G
    Rheumatology (Oxford); 2011 Feb; 50(2):343-8. PubMed ID: 20929972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta-analysis.
    Wongtrakul W; Charoenngam N; Ponvilawan B; Ungprasert P
    Int J Rheum Dis; 2020 Nov; 23(11):1460-1467. PubMed ID: 32749784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
    Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
    Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
    Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
    Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
    Chen Y; Fu L; Pu S; Xue Y
    Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
    Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
    Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.
    Fatoye F; Gebrye T; Mbada C
    Rheumatol Int; 2022 Dec; 42(12):2097-2107. PubMed ID: 36006459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
    Wang B; Shao X; Wang D; Xu D; Zhang JA
    Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
    Seo MS; Yeo J; Hwang IC; Shim JY
    Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis.
    Wang J; Liu J; Pan L; Guo L; Liu C; Yang S
    Lupus; 2021 Apr; 30(5):725-733. PubMed ID: 33557684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk of heart failure in systemic lupus erythematosus.
    Kim CH; Al-Kindi SG; Jandali B; Askari AD; Zacharias M; Oliveira GH
    Heart; 2017 Feb; 103(3):227-233. PubMed ID: 27613169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis.
    Jiang F; Li S; Jia C
    Clin Rheumatol; 2015 Nov; 34(11):1885-92. PubMed ID: 26188616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
    Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
    Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
    Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
    Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.